- 2019 INDIES Finalist
- Finalist, Health (Adult Nonfiction)
Cancer statistics are grim: one in two men and one in three women will get the disease in their lifetime. Ever more frightening is that no one in the medical industry has a decent explanation for why the incidence of cancer has increased tenfold over the past hundred years. On the bright side, oncologists are better at treating the disease, if caught early.
But cancer that has progressed to Stage 3 or beyond is a crapshoot. Even after what seems to be successful treatment, the odds of it returning in a handful of years are exceptionally high. Oh, and after fifty years and dozens of billions of dollars, oncologists are legally bound to use the same surgery/chemotherapy/radiation “standard of care” that hampers, but doesn’t terminate, the disease.
In Cancer and the New Biology of Water, Thomas Cowan presents a lengthy list of promising alternatives and complements to the standard treatment. Moreover, he details a radical new theory about how the state of the water in our cells greatly affects overall health. He writes:
The thrust of this book is that the structure and integrity of intracellular water is fundamental to the health of our cells, tissues, and our entire organism. This structure and integrity impacts cell division, transcription and translation of DNA for protein synthesis, energy generation, the charge of the cell, and is the receptor mechanism for everything from hormones and neurotransmitters to thoughts and emotions.
In other words, poor intracellular water is a welcome mat to cancer.
As in his two other important books, Cowan’s writing is compelling and eminently hopeful.
Disclosure: This article is not an endorsement, but a review. The publisher of this book provided free copies of the book to have their book reviewed by a professional reviewer. No fee was paid by the publisher for this review. Foreword Reviews only recommends books that we love. Foreword Magazine, Inc. is disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255.